Therapeutic angiogenesis

被引：8

作者：

Choksy, SA

Chan, P

机构：

[1] Univ Sheffield, No Gen Hosp, Sheffield Vasc Inst, Sheffield S5 7AU, S Yorkshire, England

[2] Univ Sheffield, No Gen Hosp, Acad Vasc Unit, Sheffield S5 7AU, S Yorkshire, England

来源：

BRITISH JOURNAL OF SURGERY | 2006年 / 93卷 / 03期

关键词：

D O I：

10.1002/bjs.5254

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

[No abstract available]

引用

页码：261 / 263

页数：3

共 10 条

[1] Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia [J].

Baumgartner, I ;

Pieczek, A ;

Manor, O ;

Blair, R ;

Kearney, M ;

Walsh, K ;

Isner, JM .

CIRCULATION, 1998, 97 (12) :1114-1123

[2] Naked plasmid DNA encoding fibroblast growth factor type I for the treatment of end-stage unreconstructible lower extremity ischemia: Preliminary results of a phase I trial [J].

Comerota, AJ ;

Throm, RC ;

Miller, KA ;

Henry, T ;

Chronos, N ;

Laird, J ;

Sequeira, R ;

Kent, CK ;

Bacchetta, M ;

Goldman, C ;

Salenius, JP ;

Schmieder, FA ;

Pilsudski, R .

JOURNAL OF VASCULAR SURGERY, 2002, 35 (05) :930-936

[3] Clinical evidence of angiogenesis after arterial gene transfer of phVEGF(165) in patient with ischaemic limb [J].

Isner, JM ;

Pieczek, A ;

Schainfeld, R ;

Blair, R ;

Haley, L ;

Asahara, T ;

Rosenfield, K ;

Razvi, S ;

Walsh, E ;

Symes, JF .

LANCET, 1996, 348 (9024) :370-374

[4] Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration [J].

Iwaguro, H ;

Yamaguchi, J ;

Kalka, C ;

Murasawa, S ;

Masuda, H ;

Hayashi, S ;

Silver, M ;

Li, T ;

Isner, JM ;

Asahara, T .

CIRCULATION, 2002, 105 (06) :732-738

[5] Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial [J].

Lederman, RJ ;

Mendelsohn, FO ;

Anderson, RD ;

Saucedo, JF ;

Tenaglia, AN ;

Hermiller, JB ;

Hillegass, WB ;

Rocha-Singh, K ;

Moon, TE ;

Whitehouse, MJ ;

Annex, BH .

LANCET, 2002, 359 (9323) :2053-2058

[6]

LOOSEMORE TM, 1994, INT ANGIOL, V13, P133

[7] Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease - A phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication [J].

Rajagopalan, S ;

Mohler, ER ;

Lederman, RJ ;

Mendelsohn, FO ;

Saucedo, JF ;

Goldman, CK ;

Blebea, J ;

Macko, J ;

Kessler, PD ;

Rasmussen, HS ;

Annex, BH .

CIRCULATION, 2003, 108 (16) :1933-1938

[8] Augmentation of postnatal neovascularization with autologous bone marrow transplantation [J].

Shintani, S ;

Murohara, T ;

Ikeda, H ;

Ueno, T ;

Sasaki, K ;

Duan, JL ;

Imaizumi, T .

CIRCULATION, 2001, 103 (06) :897-903

[9] Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial [J].

Tateishi-Yuyama, E ;

Matsubara, H ;

Murohara, T ;

Ikeda, U ;

Shintani, S ;

Masaki, H ;

Amano, K ;

Kishimoto, Y ;

Yoshimoto, K ;

Akashi, H ;

Shimada, K ;

Iwasaka, T ;

Imaizumi, T .

LANCET, 2002, 360 (9331) :427-435

[10] Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells [J].

Urbich, C ;

Heeschen, C ;

Aicher, A ;

Dernbach, E ;

Zeiher, AM ;

Dimmeler, S .

CIRCULATION, 2003, 108 (20) :2511-2516

← 1 →